↓ Skip to main content

Dove Medical Press

Dexmedetomidine for the prevention of emergence delirium and postoperative behavioral changes in pediatric patients with sevoflurane anesthesia: a double-blind, randomized trial

Overview of attention for article published in Drug Design, Development and Therapy, March 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

twitter
13 X users

Citations

dimensions_citation
80 Dimensions

Readers on

mendeley
142 Mendeley
Title
Dexmedetomidine for the prevention of emergence delirium and postoperative behavioral changes in pediatric patients with sevoflurane anesthesia: a double-blind, randomized trial
Published in
Drug Design, Development and Therapy, March 2019
DOI 10.2147/dddt.s196075
Pubmed ID
Authors

Mengzhu Shi, Shuai Miao, Tianchu Gu, Dongyue Wang, Hui Zhang, Jindong Liu

X Demographics

X Demographics

The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 142 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 142 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 26 18%
Student > Postgraduate 12 8%
Student > Bachelor 11 8%
Other 9 6%
Student > Doctoral Student 7 5%
Other 21 15%
Unknown 56 39%
Readers by discipline Count As %
Medicine and Dentistry 42 30%
Nursing and Health Professions 24 17%
Psychology 4 3%
Pharmacology, Toxicology and Pharmaceutical Science 3 2%
Biochemistry, Genetics and Molecular Biology 3 2%
Other 9 6%
Unknown 57 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 September 2019.
All research outputs
#3,454,278
of 25,728,855 outputs
Outputs from Drug Design, Development and Therapy
#202
of 2,280 outputs
Outputs of similar age
#73,833
of 369,126 outputs
Outputs of similar age from Drug Design, Development and Therapy
#3
of 39 outputs
Altmetric has tracked 25,728,855 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,280 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 369,126 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.